Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy
Journal article published in 2017 by
C. M. Gibson,
D. F. Arbetter,
P. Jain,
R. Halaby,
G. Chi 
,
T. Nafee,
S. Korjian,
Y. Daaboul,
S. Z. Goldhaber,
R. D. Hull,
A. Gold,
A. F. Hernandez,
A. T. Cohen,
R. A. Harrington
,
T. Nafee,
S. Korjian,
Y. Daaboul,
S. Z. Goldhaber,
R. D. Hull,
A. Gold,
A. F. Hernandez,
A. T. Cohen,
R. A. Harrington
